openPR Logo
Press release

Inflammatory Bowel Disease Treatment Market to Witness Substantial Growth USD 30.80 Billion, with a Dynamic 4.7% Growth Rate by 2030

06-05-2024 02:41 PM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Inflammatory Bowel Disease Treatment Market

Inflammatory Bowel Disease Treatment Market

๐“๐ก๐ž ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐ข๐ง๐Ÿ๐ฅ๐š๐ฆ๐ฆ๐š๐ญ๐จ๐ซ๐ฒ ๐›๐จ๐ฐ๐ž๐ฅ ๐๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ญ๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ข๐ฌ ๐ž๐ฑ๐ฉ๐ž๐œ๐ญ๐ž๐ ๐ญ๐จ ๐ซ๐ž๐š๐œ๐ก ๐”๐’๐ƒ ๐Ÿ‘๐ŸŽ.๐Ÿ–๐ŸŽ ๐›๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐ŸŽ, ๐ ๐ซ๐จ๐ฐ๐ข๐ง๐  ๐š๐ญ ๐š๐ง ๐Ÿ’.๐Ÿ•% ๐‚๐€๐†๐‘ ๐Ÿ๐ซ๐จ๐ฆ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ ๐ญ๐จ ๐Ÿ๐ŸŽ๐Ÿ‘๐ŸŽ. ๐ˆ๐ญ ๐ฐ๐š๐ฌ ๐ฏ๐š๐ฅ๐ฎ๐ž๐ ๐š๐ญ ๐”๐’๐ƒ ๐Ÿ๐ŸŽ.๐Ÿ’๐Ÿ” ๐›๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ.

The market is experiencing significant growth and is expected to continue expanding in the coming years.
Albeit there is no corrective cure for inflammatory bowel disease treatment, it is feasible to reduce redness and confront indicators with several therapies. The aim of curing IBD involves halting ensuing eruption and palliative redness in the intestines, both in the lining and at a profound cellular level.

As IBD frequently creates problems in varied body parts, a cross-functional perspective to care can be of assistance. Experts in gastroenterology, colorectal surgery, rheumatology, dermatology, ophthalmology, and alternate areas work cohesively to enhance the standard of living for people with IBD. The cures might involve medicines, surgeries, and a gamut of provisions and lifestyle alterations that assist in decreasing redness and reinforcing the immune system.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐€ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐“๐จ ๐†๐š๐ข๐ง ๐‚๐จ๐ฆ๐ฉ๐ซ๐ž๐ก๐ž๐ง๐ฌ๐ข๐ฏ๐ž ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ: https://www.polarismarketresearch.com/industry-analysis/global-inflammatory-bowel-disease-ibd-market/request-for-sample

๐‚๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐ข๐จ๐ง ๐‚๐š๐ญ๐ž๐ ๐จ๐ซ๐ข๐ณ๐š๐ญ๐ข๐จ๐ง

The spearheading players are now concentrating on putting programs into practice, such as utilizing contemporary technology, commodity inventions, acquisition and mergers, joint ventures, and alliances to enhance the market standing. Key companies in the inflammatory bowel disease treatment market are mentioned below:

โ€ข AbbVie Inc.
โ€ข Biogen
โ€ข Johnson & Johnson Services
โ€ข Inc.
โ€ข Amgen Inc.
โ€ข UCB S.A.
โ€ข Novartis AG
โ€ข Takeda Pharmaceutical Company Limited
โ€ข Bausch health companies Inc.
โ€ข Bristol-myers squibb company
โ€ข Merck & co. Inc.
โ€ข Pfizer Inc.
โ€ข Celltrion Inc.
โ€ข Janssen Biotech
โ€ข Allergan plc.

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‡๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ

โ€ข The demand for inflammatory bowel disease treatment is rising quickly due to growing cases of Crohn's disease and ulcerative colitis, as well as growing consciousness of the condition globally.
โ€ข The inflammatory bowel disease treatment market demand is further increased by an aggregate of prominent businesses in the sector concentrating on R&D and probing contemporary probable contenders for curing IBD.
โ€ข North America dominated the market with the largest share
โ€ข APAC is expected to grow at the quickest rate during the forecast period.

๐๐ž๐ž๐ ๐Œ๐จ๐ซ๐ž ๐…๐จ๐ซ ๐˜๐จ๐ฎ๐ซ ๐๐ฎ๐ฌ๐ข๐ง๐ž๐ฌ๐ฌ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐ƒ๐ข๐ซ๐ž๐œ๐ญ๐ฅ๐ฒ ๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‡๐ž๐ซ๐ž: https://www.polarismarketresearch.com/buy/1555/2

๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ

โ€ข Rising Prevalence of IBD: The global incidence of IBD is on the rise, contributing to increased demand for effective treatment options.
โ€ข Advancements in Biotechnology and Pharmaceuticals: Innovations in drug development, including biologics and biosimilars, have significantly improved the efficacy of IBD treatments.
โ€ข Increasing Awareness and Diagnosis: Improved diagnostic techniques and greater awareness among the public and healthcare providers have led to early detection and treatment of IBD.
โ€ข Government and Private Sector Initiatives: Supportive policies, research funding, and collaborations between governments and private organizations are fueling market growth.

๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ

โ€ข North America (U.S., Canada)
โ€ข Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
โ€ข Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
โ€ข Latin America (Brazil, Mexico, Argentina)
โ€ข Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

๐€๐œ๐œ๐ž๐ฌ๐ฌ ๐ญ๐ก๐ž ๐„๐ง๐ญ๐ข๐ซ๐ž ๐‚๐จ๐ฆ๐ฉ๐ซ๐ž๐ก๐ž๐ง๐ฌ๐ข๐ฏ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‡๐ž๐ซ๐ž: https://www.polarismarketresearch.com/industry-analysis/global-inflammatory-bowel-disease-ibd-market

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ฅ ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค

๐๐ฒ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ข๐ง๐๐ข๐œ๐š๐ญ๐ข๐จ๐ง
โ€ข Crohn's Disease
โ€ข Ulcerative Colitis

๐๐ฒ ๐ƒ๐ซ๐ฎ๐  ๐‚๐ฅ๐š๐ฌ๐ฌ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ
โ€ข Amino salicylates
โ€ข Corticosteroids
โ€ข TNF inhibitors
โ€ข IL inhibitors
โ€ข Anti-integrin
โ€ข JAK inhibitors
โ€ข Others

๐๐ฒ ๐‘๐จ๐ฎ๐ญ๐ž ๐จ๐Ÿ ๐€๐๐ฆ๐ข๐ง๐ข๐ฌ๐ญ๐ซ๐š๐ญ๐ข๐จ๐ง
โ€ข Oral
โ€ข Injectable

๐๐ฒ ๐ƒ๐ข๐ฌ๐ญ๐ซ๐ข๐›๐ฎ๐ญ๐ข๐จ๐ง ๐‚๐ก๐š๐ง๐ง๐ž๐ฅ
โ€ข Hospital Pharmacy
โ€ข Retail Pharmacy
โ€ข Online Pharmacy

๐ˆ๐ง๐Ÿ๐ฅ๐š๐ฆ๐ฆ๐š๐ญ๐จ๐ซ๐ฒ ๐๐จ๐ฐ๐ž๐ฅ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‡๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ

โ€ข In 2021, Crohn's disease dominated the IBD market. It is expected that the segment will remain dominant during the forecast period.
โ€ข The injectable category dominated the market for the treatment of inflammatory bowel disease in 2021 with a revenue share. The segment's dominance is due to the great efficacy of injectable drugs.
โ€ข The hospital pharmacy industry dominated the market for the treatment of inflammatory bowel disease in 2021, accounting for the largest revenue share. The sector is predicted to dominate the market during the forecasted period.

๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐–๐ข๐๐ž-๐ซ๐š๐ง๐ ๐ข๐ง๐  ๐‚๐จ๐ฏ๐ž๐ซ๐š๐ ๐ž ๐จ๐Ÿ ๐๐Œ๐‘'๐ฌ ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐‹๐š๐ง๐๐ฌ๐œ๐š๐ฉ๐ž:

๐†๐ž๐ง๐ž ๐“๐ก๐ž๐ซ๐š๐ฉ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ: https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market

๐„๐œ๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ ๐’๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ: https://www.polarismarketresearch.com/industry-analysis/eclinical-solutions-market

๐Œ๐ข๐œ๐ซ๐จ๐ฌ๐œ๐จ๐ฉ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ: https://www.polarismarketresearch.com/industry-analysis/microscope-market

๐Ž๐ฌ๐ญ๐จ๐ฆ๐ฒ/๐’๐ญ๐จ๐ฆ๐š ๐‚๐š๐ซ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ: https://www.polarismarketresearch.com/industry-analysis/ostomy-care-market

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ:

Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Inflammatory Bowel Disease Treatment Market to Witness Substantial Growth USD 30.80 Billion, with a Dynamic 4.7% Growth Rate by 2030 here

News-ID: 3527523 • Views: โ€ฆ

More Releases from Polaris Market Research & Consulting

Vehicle Tracking Systems Market Revenue to Cross USD 41.94 Billion By 2028; Registering at a CAGR of 13.5%
Vehicle Tracking Systems Market Revenue to Cross USD 41.94 Billion By 2028; Regi โ€ฆ
The report examines everything a marketer needs before financing in the global Vehicle Tracking Systems Industry during the forecast period 2021-2028. Vehicle Tracking Systems Market Share, Size, Trends, Industry Analysis Report, By Vehicle (Passenger, Light Commercial, Heavy Commercial); End-Use; Technology; Component, Region; Segment Forecast, 2021 - 2028. This report provides a thorough understanding of market shares, size, current trends, and sales value. A vehicle tracking system tracks and keeps an eyeโ€ฆ
Pyrogen Testing Market is anticipated to grow from USD 1.76 billion in 2024 to USD 3.42 billion by 2032, at a CAGR of 8.7% from 2024 to 2032 | PMR
Pyrogen Testing Market is anticipated to grow from USD 1.76 billion in 2024 to U โ€ฆ
๐‘ด๐’‚๐’“๐’Œ๐’†๐’• ๐‘ถ๐’—๐’†๐’“๐’—๐’Š๐’†๐’˜: The newly published research report titled Pyrogen Testing Market 2024: By Types, Applications, Size, Share, Key Players & Regions Forecast Analysis till 2032 provides in-depth knowledge about a rapidly growing sector. This comprehensive industry overview outlines the study's objectives and the research methodologies employed. It examines crucial aspects that stakeholders need to understand, including market share, size, and top trends related to Pyrogen Testing Market. Additionally, it highlights theโ€ฆ
Team Collaboration Software Market Sets New Record, Projected at USD 26.24 Billion By 2028 at 12.7% CAGR
Team Collaboration Software Market Sets New Record, Projected at USD 26.24 Billi โ€ฆ
The report examines everything a marketer needs before financing in the global Team Collaboration Software Industry during the forecast period 2021-2028. Team Collaboration Software Market Share, Size, Trends, Industry Analysis Report, By Software (Conferencing, Communication & Coordination); Application; Deployment; Region; Segment Forecast, 2021 - 2028. This report provides a thorough understanding of market shares, size, current trends, and sales value. Software for team collaboration facilitates communication, information sharing, and more effectiveโ€ฆ
Regulatory Affairs Outsourcing Market is anticipated to grow from USD 7.20 billion in 2024 to USD 13.69 billion by 2032
Regulatory Affairs Outsourcing Market is anticipated to grow from USD 7.20 billi โ€ฆ
๐™„๐™ฃ๐™™๐™ช๐™จ๐™ฉ๐™ง๐™ฎ ๐™Ž๐™ฉ๐™–๐™ฉ๐™จ: ๐™‚๐™ก๐™ค๐™—๐™–๐™ก ๐™๐™š๐™œ๐™ช๐™ก๐™–๐™ฉ๐™ค๐™ง๐™ฎ ๐˜ผ๐™›๐™›๐™–๐™ž๐™ง๐™จ ๐™Š๐™ช๐™ฉ๐™จ๐™ค๐™ช๐™ง๐™˜๐™ž๐™ฃ๐™œ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ ๐™จ๐™ž๐™ฏ๐™š ๐™–๐™ฃ๐™™ ๐™จ๐™๐™–๐™ง๐™š ๐™ž๐™จ ๐™˜๐™ช๐™ง๐™ง๐™š๐™ฃ๐™ฉ๐™ก๐™ฎ ๐™ซ๐™–๐™ก๐™ช๐™š๐™™ ๐™–๐™ฉ ๐™๐™Ž๐˜ฟ 7.20 ๐™—๐™ž๐™ก๐™ก๐™ž๐™ค๐™ฃ ๐™ž๐™ฃ 2024 ๐™–๐™ฃ๐™™ ๐™ž๐™จ ๐™–๐™ฃ๐™ฉ๐™ž๐™˜๐™ž๐™ฅ๐™–๐™ฉ๐™š๐™™ ๐™ฉ๐™ค ๐™œ๐™š๐™ฃ๐™š๐™ง๐™–๐™ฉ๐™š ๐™–๐™ฃ ๐™š๐™จ๐™ฉ๐™ž๐™ข๐™–๐™ฉ๐™š๐™™ ๐™ง๐™š๐™ซ๐™š๐™ฃ๐™ช๐™š ๐™ค๐™› ๐™๐™Ž๐˜ฟ 13.69 ๐™—๐™ž๐™ก๐™ก๐™ž๐™ค๐™ฃ ๐™—๐™ฎ 2032, ๐™–๐™˜๐™˜๐™ค๐™ง๐™™๐™ž๐™ฃ๐™œ ๐™ฉ๐™ค ๐™ฉ๐™๐™š ๐™ก๐™–๐™ฉ๐™š๐™จ๐™ฉ ๐™จ๐™ฉ๐™ช๐™™๐™ฎ ๐™—๐™ฎ ๐™‹๐™ค๐™ก๐™–๐™ง๐™ž๐™จ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ ๐™๐™š๐™จ๐™š๐™–๐™ง๐™˜๐™. ๐˜ฝ๐™š๐™จ๐™ž๐™™๐™š๐™จ, ๐™ฉ๐™๐™š ๐™ง๐™š๐™ฅ๐™ค๐™ง๐™ฉ ๐™ฃ๐™ค๐™ฉ๐™š๐™จ ๐™ฉ๐™๐™–๐™ฉ ๐™ฉ๐™๐™š ๐™ข๐™–๐™ง๐™ ๐™š๐™ฉ ๐™š๐™ญ๐™๐™ž๐™—๐™ž๐™ฉ๐™จ ๐™– ๐™ง๐™ค๐™—๐™ช๐™จ๐™ฉ 8.4% ๐˜พ๐™ค๐™ข๐™ฅ๐™ค๐™ช๐™ฃ๐™™ ๐˜ผ๐™ฃ๐™ฃ๐™ช๐™–๐™ก ๐™‚๐™ง๐™ค๐™ฌ๐™ฉ๐™ ๐™๐™–๐™ฉ๐™š (๐˜พ๐˜ผ๐™‚๐™) ๐™ค๐™ซ๐™š๐™ง ๐™ฉ๐™๐™š ๐™›๐™ค๐™ง๐™š๐™˜๐™–๐™จ๐™ฉ๐™š๐™™ ๐™ฉ๐™ž๐™ข๐™š๐™›๐™ง๐™–๐™ข๐™š, 2024 - 2032 ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ ๐™Š๐™ซ๐™š๐™ง๐™ซ๐™ž๐™š๐™ฌ: The newly published research reportโ€ฆ

All 5 Releases


More Releases for IBD

Canada Inflammatory Bowel Disease (IBD) Market Size & Growth Analysis Report, 20 โ€ฆ
The Canada IBD market is estimated to grow significantly at a CAGR of around 5.2% during the forecast period. Rising prevalence and incidence of IBD across the country is the major driving factor for the market. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per CCC, in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohnโ€™s disease,โ€ฆ
Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031
Visiongain has published a new report on Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031: Forecasts by Drug Class (Biologics, Aminosalicylates, Corticosteroids, Antibiotics, Immunomodulators, Others), by Indication (Crohnโ€™s Disease, Ulcerative Colitis), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) AND Regional and Leading National Market Analysis PLUS Analysis of Leading IBD Drug Companies AND COVID-19 Recovery Scenarios. Global Inflammatory Bowel Disease (IBD) drugs market was valued at US$ US$xxโ€ฆ
US Inflammatory Bowel Disease (IBD) Therapeutics Market Research and Forecast 20 โ€ฆ
The US IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.7% during the forecast period. The factors such as the significant prevalence of IBD such as Crohnโ€™s disease and ulcerative colitis across the country contributing to the market growth. As per the Centers for Disease Control and Prevention (CDC), the prevalence of Crohnโ€™s disease and ulcerative colitis in the US was 201 and 238 perโ€ฆ
France Inflammatory Bowel Disease (IBD) Therapeutics Market Size, Growth and For โ€ฆ
France IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.6% during the forecast period. The growing IBD patient population is one of the major driving forces for the growth of the market in the country. According to the National Institutes of, Health, the total number of cases associated with Crohn's disease in France were registered to be around 72,522 in 2017. This signifies the opportunityโ€ฆ
Global Inflammatory Bowel Disease (IBD) Therapeutics Market, Share, Trends & For โ€ฆ
The global IBD therapeutics market is estimated to grow significantly at a CAGR of around 5.0% during the forecast period. The rise in the number of IBD such as Crohn's disease and ulcerative colitis is augmenting the growth of the global IBD therapeutics market. The increasing prevalence of IBD results in the need for research for the treatment of IBD and innovations in healthcare systems to manage this complex andโ€ฆ
Canada Inflammatory Bowel Disease (IBD) Market Share, Size & Forecast to 2025
The Canada IBD market is estimated to grow significantly at a CAGR of around 5.2% during the forecast period. Rising prevalence and incidence of IBD across the country is the major driving factor for the market. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per CCC, in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohn's disease,โ€ฆ